In the final part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, illustrates how data-driven ...

In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceutical companies must move from traditional ...

A systematic review determines if adult patients with language barriers are less likely to use the video-based virtual care ...

An Applied Clinical Trials article explores the complex and often conflicting perspectives of sponsors, CROs, and research sites on fair market value in clinical trial budgeting, emphasizing the need ...

In the second part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, details what the company’s ...

Marketed as BNT327, the PD-L1xVEGF-A bispecific antibody has the potential to become what the involved parties believe is a ...

In an effort to greater prepare HCPs and to avoid potential shortages, the company targets Q3 as the shipment date. Sanofi is shipping Beyfortus early to ensure strong supply for the 2025–2026 RSV ...

Ron Lanton, Partner, Lanton Law, weighs in on the potential international trade, pricing, and access implications of tying US drug costs to those in other developed countries under the Most Favored ...

In the first part of his Pharma Commerce video interview, Scott Tillman, Logility’s senior vice president of innovation, ...

Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug ...

Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than ...